Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Ann Intern Med. 2021 Nov 16;175(1):1–10. doi: 10.7326/M21-1550

Appendix Table 3.

Risk Difference of Influenza Vaccination Uptakes by Category and High-Risk,* Status, 2018 to 2019 Influenza Season

Characteristic Comparison Within Category, Risk Difference (95% Confidence Limit)
Comparison by High-Risk Status (High Risk Minus Non-High Risk), Risk Difference (95% Confidence Limit)
High Risk Non-High Risk Total

Total - - - 28.5 (28.5 to 28.6)
Age group
 19–49 y −22.1 (−22.2 to −22.0) −19.4 (−19.5 to −19.3) −23.8 (−23.9 to −23.7) 22.7 (22.5 to 22.8)
 50–64 y −15.2 (−15.3 to −15.1) −16.5 (−16.6 to −16.4) −14.4 (−14.5 to −14.3) 26.7 (26.6 to 26.8)
 65–74 y Referent Referent Referent 25.3 (25.3 to 25.4)
 ≥75 y 7.3 (7.3 to 7.3) 5.0 (4.9 to 5.1) 10.6 (10.5 to 10.6) 27.6 (27.6 to 27.7)
Sex
 Male Referent Referent Referent 32.7 (32.7 to 32.8)
 Female 3.0 (3.0 to 3.0) 11.9 (11.8 to 12.0) 6.0 (6.0 to 6.0) 23.8 (23.8 to 23.9)
Race/ethnicity
 White Referent Referent Referent 27.5 (27.5 to 27.6)
 Black −17.1 (−17.1 to −17.0) −21.2 (−21.2 to −21.1) − 17.9 (−18.0 to −17.9) 31.6 (31.5 to 31.7)
 Hispanic −19.7 (−19.8 to −19.6) −21.9 (−22.1 to −21.8) −22.5 (−22.6 to −22.3) 29.8 (29.6 to 30.0)
 Asian −0.1 (−0.3 to 0.0) −9.5 (−9.7 to −9.2) −2.7 (−2.8 to −2.5) 36.9 (36.6 to 37.1)
 Other −4.2 (−4.4 to −4.1) −8.7 (−8.9 to −8.5) −6.0 (−6.1 to −5.9) 32.0 (31.8 to 32.2)
Region
 Midwest 5.5 (5.4 to 5.6) 4.9 (4.8 to 5.0) 6.6 (6.6 to 6.7) 26.6 (26.6 to 26.7)
 Northeast 8.3 (8.3 to 8.4) 2.6 (2.5 to 2.7) 9.2 (9.1 to 9.2) 31.8 (31.7 to 31.9)
 South 3.0 (2.9 to 3.0) −0.2 (−0.3 to −0.1) 4.3 (4.2 to 4.3) 29.2 (29.1 to 29.2)
 West Referent Referent Referent 26.1 (26.0 to 26.1)
Dual eligibility for Medicare and Medicaid
 Dual eligible −15.3 (−15.3 to −15.2) −15.2 (−15.3 to −15.1) −14.2 (−14.2 to −14.1) 29.0 (29.0 to 29.1)
 Not dual eligible Referent Referent Referent 29.0 (29.0 to 29.1)
Type of provider visited for E/M
 None Referent Referent Referent 11.7 (11.6 to 11.7)
 PCP 33.1 (33.1 to 33.2) 30.8 (30.7 to 30.9) 39.8 (39.7 to 39.8) 14.0 (13.9 to 14.1)
 PCP and specialist 42.3 (42.2 to 42.4) 44.4 (44.2 to 44.6) 49.9 (49.8 to 49.9) 9.5 (9.4 to 9.7)
 Specialist 35.4 (35.3 to 35.5) 33.3 (33.1 to 33.4) 41.5 (41.4 to 41.5) 13.8 (13.7 to 14.0)
 Others 24.6 (24.5 to 24.8) 20.8 (20.7 to 20.9) 29.6 (29.6 to 29.7) 15.5 (15.4 to 15.6)
Number of E/M visits
 0 Referent Referent Referent 11.7 (11.6 to 11.7)
 1 21.3 (21.2 to 21.4) 21.5 (21.4 to 21.6) 25.9 (25.8 to 25.9) 11.4 (11.3 to 11.6)
 ≥2 35.0 (34.9 to 35.1) 31.7 (31.7 to 31.8) 41.7 (41.7 to 41.7) 14.9 (14.9 to 15.0)
Number of E/M visits to PCP
 0 Referent Referent Referent 26.9 (26.9 to 27.0)
 1 7.5 (7.4 to 7.5) 22.2 (22.1 to 22.3) 14.4 (14.4 to 14.5) 12.2 (12.1 to 12.3)
 ≥2 13.3 (13.2 to 13.3) 26.7 (26.5 to 26.8) 21.3 (21.3 to 21.4) 13.6 (13.4 to 13.7)
Number of E/M visits to specialist
 0 Referent Referent Referent 27.9 (27.9 to 27.9)
 1 10.5 (10.4 to 10.6) 24.8 (24.7 to 25.0) 15.6 (15.6 to 15.7) 13.6 (13.4 to 13.7)
 ≥2 13.2 (13.2 to 13.3) 27.4 (27.2 to 27.6) 19.1 (19.1 to 19.2) 13.7 (13.5 to 13.9)

E/M = evaluation and management; PCP = primary care provider.

*

Indicates diagnosis with a condition associated with elevated risk for influenza complications.

The risk differences are estimated based on the uptakes reported in Table 1.

Includes clinics or group practices; nonphysician providers (including nurse practitioners, physician assistants, and clinical nurse specialists); ambulatory outpatient facilities, such as end-stage renal disease facilities; and institutional providers, such as hospitals, skilled-nursing facilities, and home health agencies.